-
Innovation Ranking
Innovation Ranking - Yeti Holdings Inc
Yeti Holdings Inc (Yeti) operates as a holding company that design, marketing and distribution of products for the outdoor and recreation market. The company offering products includes coolers, drink ware, bags, buckets, chairs, blankets, dog bowls and beds, apparel and accessories. Its cooler products offer hard cooler, soft cooler, wheeled cooler and accessories. Yeti bags comprise backpacks, tote bags, duffels, luggage, waterproof bags and lunch bags. The company also provides Activities Products for fishing, hunting, camping and snowboarding, among others....
-
Innovation Ranking
Innovation Ranking - Lamb Weston Holdings Inc
Lamb Weston Holdings Inc (Lamb Weston) is a manufacturer and marketer of frozen potato products. The company’s product portfolio comprises fries, sweet potato fries, other potato products and appetizers. Lamb Weston offers products in several varieties, including straight, sliced, diced and mashed. The company markets its products under Lamb Weston, Lamb Weston Supreme, Lamb Weston Private Reserve, Lamb Weston Colossal Crisp, Lamb Weston Stealth Fries, Lamb Weston Seasoned, Lamb Weston Crispy on Delivery, and Sweet Things brand names. It distributes...
-
Innovation Ranking
Innovation Ranking - Praxis Precision Medicines Inc
Praxis Precision Medicines Inc (Praxis) is a clinical-stage biopharmaceutical company that translates genetic insights for the development of novel therapies to treat central nervous system disorders. The company’s pipeline program includes PRAX-114, PRAX-944, PRAXIS-050 and PRAXIS-040 which are molecule GABA receptors for the treatment of psychiatry and movement disorders. Praxis provides programs such as PRAX-562, PRAX-222, PRAX-020, SCN2A-LCF, SYNGAP1, PCDH19, and PRAXIS-030 are used for the treatment of genetic epilepsies. Praxis is headquartered in Cambridge, Massachusetts, the US.
-
Innovation Ranking
Innovation Ranking - BridgeBio Pharma Inc
BridgeBio Pharma Inc (BridgeBio) is a clinical-stage biotechnology company that develops novel medicines for genetic diseases. The company’s pipeline product portfolio includes precision cardiorenal drugs such as acoramidis, encaleret, BBP-711; mendelian disease drugs which include acoramidis, fosdenopterin, patidegib topical gel, low-dose infigratnib, BBP-589, BBP-551, BBP-418, BBP-681, BBP-671, among others; precision oncology drugs which include high-dose infigratinib, BBP-398, BBP-454, BBP-954. BridgeBio also carries out various phases of clinical trials such as pre-clinical, phase I, phase II studies. The company’s academic partners...
-
Innovation Ranking
Innovation Ranking - Cue Biopharma Inc
Cue Biopharma Inc (Cue Biopharma) operates as pharmaceutical company. The company develops biologic drugs for human immune system to treat cancers and autoimmune disorders. The company’s pipeline products include CUE-100 series to improve various tumor specific T cells Browse. CUE-200 series to give a boost to exhausted T cells and CUE-300 series. It offers therapy in areas of immuno onncology, infectious diseases and autoimmune diseases. The company's proprietary Immuno-STAT™ (Selective Targeting and Alteration of T cells) platform, is designed to...
-
Innovation Ranking
Innovation Ranking - Vir Biotechnology Inc
Vir Biotechnology Inc (Vir) is a biotechnology company which carries out the development of therapeutic products to prevent and treat serious infectious diseases. It develops treatments for viral and bacterial diseases and induce protective and therapeutic immune responses. The company includes in multi-program, multi-platform approach. Vir focuses on chronic infectious diseases including hepatitis B, tuberculosis, HIV; respiratory diseases, including influenza, respiratory syncytial virus (RSV) and metapneumovirus (MPV), healthcare-acquired infections. It has operations in Portland, Oregon, Boston, Massachusetts, Bellinzona, Switzerland. Vir...
-
Innovation Ranking
Innovation Ranking - Idorsia Pharmaceutical Ltd
Idorsia Pharmaceutical Ltd (Idorsia) is a biopharmaceutical company that discovers, develops, and commercializes small molecules to treat the central nervous system and cardiovascular and immunological disorders. It is investigating daridorexant against insomnia; aprocitentan for the treatment of resistant hypertension; clazosentan to treat cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage; and L-lucerastat compound targeting fabry disease. The company is also evaluating drugs against suspected acute myocardial infarction, systemic lupus erythematosus, Binge eating disorder and rare lysosomal storage disorders. It works in...
-
Innovation Ranking
Innovation Ranking - WuXi Biologics Cayman Inc
WuXi Biologics Cayman Inc (Wuxi Biologics) provides solutions to discover, develop and manufacture biologics. The company offers protein generation, assay development, antibody generation, screening, characterization and optimization, regulatory affairs and testing services. It utilizes WuXiBody bispecific antibody platform to discover antibodies, CRISPR gene editing technology for improving cell growth and productivity and microbial expression and a fermentation platform to manufacture new proteins and plasmids. Wuxi Biologics also provides cell culture development and manufacturing, scale-out manufacturing and other services through its...
-
Innovation Ranking
Innovation Ranking - Fujian Anjoy Foods Co Ltd
Anjoy Foods Group Co., Ltd (Anjoy Foods), formerly a Fujian Anjoy Foods Co Ltd, is a producer of quick-frozen food including hot pot ingredient products, frozen rice and wheat flour products. The company provides its product in hotpot, noodle and dishes. It offers stuffing, pills, fried, intestines, barbecue, slice, imitation crab, marunouchi series, fresh lock, dumplings, steamed buns, hanampaakcik point series, dim sum series, fried products, meat, soy products, tofu, cake, churros, rice balls and egg dumplings. The company also...
-
Innovation Ranking
Innovation Ranking - Krystal Biotech Inc
Krystal Biotech Inc (Krystal Biotech) is a gene therapy company that develops and commercializes treatments for dermatological diseases. The company’s pipeline includes B-VEC (bercolagene telserpavec) gene therapy, against dystrophic epidermolysis bullosa (DEB), KB105 therapy, targeting autosomal recessive congenital ichthyosis (ARCI), a genetic skin disease caused due to deficiency of TGM1 gene. Krystal Biotech also investigating KB301, to treat aesthetic skin conditions, KB104, against Netherton Syndrome, KB407, for the treatment of Junctional Epidermolysis Bullosa (JEB) and KB5XX, targeting chronic skin diseases....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.